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Ethnopharmacological  relevance:  Achillea  millefolium  L. (Asteraceae),  known  as yarrow  (“mil  folhas”),  has
been used  as  folk  medicine  for gastrointestinal  disorders,  inﬂammation,  anxiety,  and  insomnia.
Aim:  To  evaluate  the potential  anxiolytic-like  effect  of  hydroalcoholic  extract  of  Achillea  millefolium  L.  in
animal  models.
Methods: The  present  study  evaluated  the  effects  of  the  hydroalcoholic  extract  from  the  aerial  parts
of  Achillea  millefolium  L. in  mice  subjected  to  the  elevated  plus-maze,  marble-burying,  and  open-ﬁeld
tests.  Additionally,  the  GABAA/benzodiazepine  (BDZ)  mediation  of the  effects  of Achillea  millefolium  was
evaluated  by  pretreatment  with  the  noncompetitive  GABAA receptor  antagonist  picrotoxin  and  the  BDZ
antagonist  ﬂumazenil  and  by [3H]-ﬂunitrazepam  binding  to the  BDZ  site  on the  GABAA receptor.
Results: Achillea  millefolium  exerted  anxiolytic-like  effects  in  the elevated  plus-maze  and  marble-burying
test  after  acute  and  chronic  (25 days)  administration  at doses  that  did  not  alter  locomotor  activity.  ThisABA antagonist
lumazenil
icrotoxin
behavioral  proﬁle  was  similar  to  diazepam.  The  effects  of  Achillea  millefolium  in  the  elevated  plus-maze
were  not  altered  by  picrotoxin  pretreatment  but  were  partially  blocked  by ﬂumazenil.  Furthermore,
Achillea  millefolium  did  not  induce  any  changes  in [3H]-ﬂunitrazepam  binding.
Conclusion:  The  results  indicate  that  the  orally  administered  hydroalcoholic  extract  of  Achillea  millefolium
L. exerted  anxiolytic-like  effects  that  likely  were  not  mediated  by GABAA/BDZ  neurotransmission  and  did
not present  tolerance  after  short-term,  repeated  administration.
© 2011 Elsevier Ireland Ltd. Open access under the Elsevier OA license.. Introduction
Numerous traditionally used plants exhibit pharmacological
roperties with great potential for therapeutic applications in the
reatment of central nervous system disorders, such as anxiety dis-
rders (Carlini, 2003; Faustino et al., 2010). Achillea millefolium L.
Asteraceae), known as yarrow (“mil folhas”), is a perennial herb
hat has been used for hundreds of years in folk medicine in sev-
ral countries (Chandler et al., 1982; Wichtl and Bisset, 1989). In
ermany and Italy, it is used for the treatment of gastrointestinal
∗ Corresponding author at: Instituto de Ciências Biológicas, Médicas e da Saúde –
armacologia, Universidade Paranaense, Umuarama 87502-210, PR, Brazil.
el.: +55 44 3621 28228x1403; fax: +55 44 3621 28228x1403.
E-mail addresses: irineiapaulina@hotmail.com, neia@unipar.br (I.P. Baretta).
378-8741     © 2011 Elsevier Ireland Ltd.  
oi:10.1016/j.jep.2011.11.047
Open access under the Elsevier OA license.disturbances. In Britain and North America, it is used to treat bleed-
ing (Bruneton, 1999; Willuhn, 2002; Applequist and Moerman,
2011). In Brazil, its main indication is for the treatment of pain,
wounds, inﬂammation, and gastrointestinal complaints (Dalsenter
et al., 2004; Cavalcanti et al., 2006; Pires et al., 2009), although plant
infusion or the decoction of the aerial parts of the plant is indicated
for “calmness” (Manfrini et al., 2009). This latter indication is also
seen in Mexico (Molina-Hernandez et al., 2004).
Previous preclinical studies have corroborated its safety and
antinociceptive and antiulcer effects (Dalsenter et al., 2004;
Cavalcanti et al., 2006; Pires et al., 2009). Although Achillea mille-
folium L. has been proposed as a folk remedy in the treatment
of central nervous system disorders, very few data have been
published supporting this claimed ethomedical action. Molina-
Hernandez et al. (2004) used a conﬂict operant procedure and
showed that the anticonﬂict-like actions of an aqueous extract of
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mal  was tested in the open-ﬁeld test 5 min  before testing in the
elevated plus maze. The mice were habituated to the experimentalI.P. Baretta et al. / Journal of Et
he ﬂowers of Achillea millefolium L. administered intraperitoneally
ary according to the estrous cycle phase of female rats.
The search for new anxiolytic drugs is supported by the adverse
ffects associated with the current drug treatments for generalized
nxiety disorder. Benzodiazepines (BDZs) can lead to disturb-
ng effects, such as amnesia, dependence liability, and sedation.
uspirone is associated with low patient satisfaction. Moreover,
ntidepressants can lead to sexual dysfunction, insomnia, and gas-
rointestinal disturbances (Andreatini et al., 2001; Carlini, 2003;
itte et al., 2005). Medicinal plants continue to have anxiolytic
otential (Carlini, 2003; Faustino et al., 2010).
The elevated plus maze is likely the most frequently used animal
odel for studying anxiety and anxiolytic-like drugs (Carobrez and
ertoglio, 2005). It is based on the conﬂict between the fear of open
reas on the open arms and neophobia (fear of new environments),
hich elicit avoidance behavior, and the drive to explore new
nvironments, which elicits approach behavior (Rodgers and Cole,
994; Rodgers and Dalvi, 1997). Thus, it is related to unconditioned
ehavior, although some learned behavior occurs during the exper-
mental session (Rodgers and Cole, 1994; Carobrez and Bertoglio,
005). Most anxiolytic-like drugs increase open arm exploration,
eﬂected by an increase in the percentage of entries into and time
pent on the open arms, at doses that do not affect locomotor
ctivity (Lister, 1987; Borsini et al., 2002). However, debatable
s whether the elevated plus maze can detect the anxiolytic-like
ffects of antidepressants, such as selective serotonin reuptake
nhibitors (Rodgers and Cole, 1994; Borsini et al., 2002). Marble-
urying behavior in mice and rats is based on the behavior of
urying harmless objects (Nicolas et al., 2006; Thomas et al., 2009).
his model is also related to an unconditioned behavior. Anxiolytic-
ike drugs decrease the number of marbles buried during a session
t doses that do not alter locomotor activity (Njung’e and Handley,
991; Borsini et al., 2002; Nicolas et al., 2006). These models have
ome differences. The elevated plus maze is affected by an ani-
al’s previous maze experience, whereas marble-burying behavior
s stable across repeated tests (Rodgers and Cole, 1994; Carobrez
nd Bertoglio, 2005; Thomas et al., 2009; Gomes et al., 2011). There
re some criticisms of the marble-burying model as a model of
nxiety or defensive behavior (Londei et al., 1998; Thomas et al.,
009). Marble-burying behavior has been considered a persever-
tive behavior related to obsessive compulsive disorder (Londei
t al., 1998; Costa et al., 2011; Gomes et al., 2011). However, it
s sensitive to benzodiazepines and antidepressants (Njung’e and
andley, 1991; Borsini et al., 2002; Nicolas et al., 2006), which may
ake it suitable for screening anxiolytic-like drugs. Considering the
ossibility of false-positive and false-negative results with these
nimal models (Borsini et al., 2002; Nicolas et al., 2006), in the
resent study these two models were used in a complementary
anner.
Thus, the objective of the present study was to evaluate the
ffects of acute and chronic oral treatment with the hydroalcoholic
xtract of the aerial parts of Achillea millefolium L. in mice sub-
ected to the elevated plus maze, marble-burying, and open-ﬁeld
ests. Additionally, the GABAA/benzodiazepine (BDZ) mediation of
he effects of Achillea millefolium was evaluated by pretreatment
ith the noncompetitive GABAA receptor antagonist picrotoxin and
he BDZ antagonist ﬂumazenil and by [3H]-ﬂunitrazepam binding
o the BDZ site on the GABAA receptor. Considering that apigenin
s an important constituent of Achillea millefolium extracts (Pires
t al., 2009; Tuberoso et al., 2009) and that previous studies have
uggested an anxiolytic-like effect of this compound (Viola et al.,
995; Paladini et al., 1999), the effect of apigenin was  also inves-
igated, at a dose range similar to that which would be found in
chillea millefolium extract (0.1–1.1%; Pires et al., 2009; Tuberoso
t al., 2009), in the elevated plus-maze and marble-burying
est.armacology 140 (2012) 46– 54 47
2. Materials and methods
2.1. Plant material
The Achillea millefolium used in our experiments was collected in
July 2007 from the botanical garden of the Universidade Paranaense
campus, Umuarama, Brazil, at an altitude of 430 m above sea
level (S23◦47′55–W53◦18′48). The plant was  identiﬁed by Dr.
Mariza Barion Romagnolo (Department of Botany, Universidade
Paranaense, PR, Brazil). Voucher specimens were deposited at the
herbarium of the university (specimen no. 1896).
2.2. Preparation of hydroalcoholic extract
The aerial parts (leaves, stalks, and stems) of Achillea millefolium
were air-dried in an oven at 40 ◦C for 4 days, and then the dry
plant was  cut and pulverized. The dried, powdered plant material
was  macerated for 7 days using 90% ethanol as a solvent. The sol-
vent was then eliminated using a rotary vacuum evaporator under
reduced pressure and lyophilized, yielding an extract of 17.4% of
the dry material (Potrich et al., 2010). The hydroalcoholic extract
was  dissolved in a 5% Tween-80 aqueous solution and administered
at doses ranging from 30 to 600 mg/kg.
2.3. Animals
Animals were adult albino Swiss male mice (30–45 g) from
our breeding stock. They were housed in groups in polypropylene
cages with wood shavings as bedding, under a controlled 12 h/12 h
light/dark cycle (lights on at 7:00 a.m.) and controlled temperature
(22 ◦C). The animals had free access to water and food, with the
exception of 1 h before and during the experiments. The animals
were not speciﬁcally handled prior to the experiments, with the
exception of handling during necessary animal care (e.g., cleaning
the cages) and drug administration (weighing, tail marking, and
drug administration).
2.4. Drugs and treatments
The hydroalcoholic extract of Achillea millefolium
(30–300 mg/kg), diazepam (0.75 mg/kg; Sigma, USA), and Achillea
millefolium vehicle were administered by gavage (per os, p.o.) 1 h
before the tests. Flumazenil (1.0 mg/kg, Sigma; Lolli et al., 2007;
Kamei et al., 2009) and picrotoxin (1.0 mg/kg, Sigma; Stankevicius
et al., 2008) were administered intraperitoneally (i.p.) 30 min
before the administration of the hydroalcoholic extract of Achillea
millefolium (300 mg/kg). All treatments were administered at a
constant volume of 10 mL/kg body weight. The Achillea millefolium
dose was  based on a preliminary pharmacological screening
protocol (Pires et al., 2009) with different extract doses (100, 300,
and 600 mg/kg) administered to mice. At all doses used, no signs
of acute toxicity (e.g., seizures, abdominal pain, and death) were
observed.
The apigenin doses (0.3, 1.0, and 3.0 mg/kg; Sigma) were calcu-
lated based on apigenin content in Achillea millefolium extract: 0.1%
(Tuberoso et al., 2009)–1.1% (Pires et al., 2009).
2.5. Behavioral tests
In the acute experiments, each animal was tested in only one
behavioral test, whereas in the chronic experiment, the same ani-room 1 h before the tests. The procedures used in the present study
were in accordance with the guidelines for animal research care
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rom Colégio Brasileiro de Experimentac¸ ão Animal (Brazilian Col-
ege for Animal Experimentation) and the United States National
nstitutes of Health Guide for the Care and Use of Laboratory
nimals (publication no. 85-23, revised 1985). The experimental
rotocol was approved by the Institutional Ethics Committee of the
niversidade Paranaense (approved number 13.911). The experi-
ents were performed in the morning (8–12 h, beginning 1 h after
ights on), and the illumination level was 200 lux in the experimen-
al room.
.5.1. Elevated plus maze
The elevated plus maze for mice consisted of two perpendicu-
ar open arms (30 cm × 5 cm)  and two perpendicular closed arms
30 cm × 5 cm × 25 cm)  that were open on the top. The maze was
onstructed of black painted wood and was elevated 45 cm above
he ﬂoor (Lister, 1987). The open arms were surrounded by a wood
im (0.5 cm high) to prevent the mice from falling from the maze.
ne hour after oral treatment, the mouse was placed in the center
f the elevated plus maze facing one closed arm and observed for
 min. During the test period, the following variables were mea-
ured: the number of entries into and time spent on the open and
losed arms and the total number of arm entries. Arm entries were
eﬁned as the entry of all four paws into the arm. Anxiolytic com-
ounds selectively increase the percentage of time spent on the
pen arms (open × 100/300) and percentage of open arm entries
open × 100/(open + closed)]. These effects are observed without
hanges in locomotor activity, which is measured in the elevated
lus maze as the total number of arm entries (number of open arm
ntries + number of closed arm entries; Lister, 1987; de Castro et al.,
007; Raupp et al., 2008). Before each test, the maze was  cleaned
ith 10% (v/v) ethanol solution and dry cloths.
.5.2. Open-ﬁeld test
Open-ﬁeld activity was measured in an acrylic cage (17 cm
eight, 30 cm length, 30 cm width) with a black ﬂoor marked with
hite lines in 10 cm2 areas. One hour after drug administration,
ach mouse was placed in the arena, and its ambulation in the
eripheral area, rearing, grooming, and defecation were recorded
or 5 min  (Hellión-Ibarrola et al., 2006). The number of gridlines
rossed by both hind feet in a 5 min  period was counted as an index
f ambulation. After each trial, the open-ﬁeld apparatus was wiped
lean with a 10% ethanol solution.
.5.3. Marble-burying test
One hour after drug administration, each mouse was placed
ndividually in a propylene cage that was identical to its home
age (28 cm × 16 cm × 12 cm)  and contained 5 cm deep sawdust
nd 24 clean glass marbles equally spaced against the wall. No food
r water was present. The number of marbles that were at least
wo-thirds buried after 30 min  was recorded (Skalisz et al., 2004;
ekeyne et al., 2008).
.6. [3H]-ﬂunitrazepam binding
For membrane preparation, the brains (without cerebellum)
f rats were homogenized (1:10, w/v) in homogenization buffer
10 mM  Tris–HCl, 300 mM sucrose, 2 mM EDTA, pH 7.4). The
omogenate was  centrifuged at 4 ◦C at 1000 × g for 10 min, and
he supernatant was collected from this initial centrifugation and
entrifuged again at 4 ◦C at 16,000 × g for 20 min. The pellet was
esuspended in the same buffer and frozen at −20 ◦C for 48 h. After
his period, membranes were defrosted, resuspended (1:20, w/v) in
0 mM Tris–HCl and 2 mM EDTA (pH 7.4), and centrifuged at 4 ◦C
t 16,000 × g for 10 min. The pellet was resuspended in the same
uffer and incubated at 37 ◦C for 30 min. After incubation, the pel-
ets were centrifuged and washed in the same conditions describedarmacology 140 (2012) 46– 54
above two more times. After the last centrifugation, the pellets were
resuspended in 20 mM HEPES and 1 mM EDTA (pH 7.4), and the
protein content was determined according to Bradford (1976).
The [3H]-ﬂunitrazepam binding assay was  performed as pre-
viously described (Vogel, 2008). The incubation was  carried out
in duplicate in polycarbonated tubes (total volume 500 L) con-
taining 50 mM Tris–HCl (pH 7.4), 0.5 mg  of protein membrane in
absence or presence of the crude hydroethanolic extract of plant
Achillea millefolium (1–100 g/ml). Diazepam (10 M) was used as
a positive control. The diazepam concentration was  based on pre-
vious studies, in which the IC50 of [3H]-ﬂunitrazepam binding was
approximately 10 nM (Thomas et al., 1997; Huen et al., 2003). Thus,
we used a 1000-fold higher concentration of diazepam (10 M)
to guarantee large receptor occupancy and an inhibitory effect.
Regarding the concentrations of the extract (1–100 g/ml), we
tested it in a range as low as the concentration of diazepam (10 M
corresponds to 3 g/ml) and as high as the solubility limit of the
extract (100 g/ml in aqueous solution). Incubation was started by
adding 1 nM [3H]-ﬂunitrazepam (85 Ci/mmol, Perkin-Elmer, USA),
and run at ice for 60 min. The reaction was stopped by vacuum
ﬁltration, and each ﬁlter was  washed with 15 mL of cold 10 mM
Tris–HCl buffer. Filters were individually placed in polycarbon-
ate tubes, and 1 mL  of scintillation liquid was added. Radioactivity
was  determined using a Packard Tri-Carb 2100TR liquid scintilla-
tion counter. Nonspeciﬁc binding (10–20% of total binding) was
determined by adding 100 M diazepam to the medium in paral-
lel assays. Speciﬁc binding was  considered the difference between
total binding and nonspeciﬁc binding. The results are expressed as
a percentage of speciﬁc binding.
2.7. Statistical analysis
The elevated plus maze, marble-burying, and open-ﬁeld data
were analyzed by one-way (treatment) analysis of variance
(ANOVA) for independent samples followed by the Duncan test,
with the exception of the total number of arm entries in the elevated
plus maze and number of fecal boluses in the open-ﬁeld test, which
were analyzed by Kruskal–Wallis ANOVA followed by multiple
comparison test. [3H]-ﬂunitrazepam binding data were analyzed by
one-way (treatment) ANOVA followed by Student Newman–Keuls’
test. Statistical signiﬁcance was set at P ≤ 0.05. Data are expressed
as mean ± standard error of the mean (SEM). All statistical analyses
were performed using Statistica software (StatSoft, Tulsa, OK, USA).
3. Results
3.1. Effects of acute and chronic administration of the
hydroalcoholic extract of Achillea millefolium L. in the elevated
plus maze
The results of acute and chronic administration of the hydroal-
coholic extract of Achillea millefolium L. in the elevated plus maze
are shown in Fig. 1. One-way ANOVA indicated a difference
between groups in the percentage of entries in the open arms with
acute and chronic treatments (acute: F5,54 = 9.56, P < 0.001; chronic:
F3,36 = 18.85, P < 0.001) and in the percentage of time spent in the
open arms (acute: F5,54 = 22.71, P < 0.001; chronic: F3,36 = 48.93,
P < 0.001). In the acute treatment groups, diazepam and the Achil-
lea millefolium extract (300–600 mg/kg) increased the percentage
of entries into and time spent on the open arms compared with
vehicle and the lower doses (30 and 100 mg/kg) of the Achillea
millefolium extract (all P < 0.05). Similar results were seen in the
chronic experiments: diazepam and the Achillea millefolium extract
(30–300 mg/kg) increased the percentage of entries into and time
spent on the open arms compared with vehicle (all P < 0.01). The
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Table 1
Effects of acute and chronic (25 days) treatment with the hydroalcoholic extract of Achillea millefolium (300 mg/kg) and diazepam (0.75 mg/kg) on open-ﬁeld behavior in
male  mice.
Locomotor activity (number of lines crossed) Rearing (number) Grooming time (s)
Acute
Vehicle 41 ± 8 8 ± 3 4 ± 1
Achillea millefolium 57 ± 7 9 ± 3 2 ± 1
Diazepam 68 ± 9 7 ± 2 3 ± 1
Chronic
Vehicle 60 ± 5 17 ± 3 7 ± 1
Achillea millefolium 68 ± 5 12 ± 2 3 ± 1
D
F
0
D
(Diazepam 69 ± 11 
ata are expressed as mean ± SEM; n = 10 mice/group. All treatments were administered
ig. 1. Effects of acute (left) and chronic (25 days; right) oral administration of the hydr
.75  mg/kg) on the percentage of time spent on the open arms, percentage of entries into
ata  are expressed as mean ± SEM (n = 10 mice/group). aP < 0.05, aaP < 0.01 and aaaP < 0.00
acute)  or AM 30 (chronic); cP < 0.05 compared to AM 300.15 ± 3 6 ± 2
 orally.
oalcoholic extract of Achillea millefolium (AM, 30–600 mg/kg) and diazepam (DZP,
 the open arms, and total number of arm entries in 5 min  in the elevated plus maze.
1, compared with vehicle; bP < 0.05 and bbP < 0.01 compared to AM 30 and AM 100
50 I.P. Baretta et al. / Journal of Ethnopharmacology 140 (2012) 46– 54
F  hydroalcoholic extract of Achillea millefolium (AM, 30–600 mg/kg) and diazepam (DZP,
0 as at least two-thirds buried with bedding material. Data are expressed as mean ± SEM
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Fig. 3. Effects of acute oral administration of the hydroalcoholic extract of Achil-
lea  millefolium L. (300 mg/kg) following ﬂumazenil (1.0 mg/kg, i.p.), picrotoxin
(1.0 mg/kg, i.p.), or vehicle (i.p.) pretreatment on the percentage of time spentig. 2. Effects of acute (left) and chronic (25 days; right) oral administration of the
.75  mg/kg) in the marble-burying test. A marble was considered buried when it w
n  = 10 mice/group). aP < 0.05, aaP < 0.01 and aaaP < 0.001 compared with vehicle.
umber of total arm entries did not exhibit any differences after
cute (F5,54 = 1.20, P > 0.05) and chronic administration (F3,36 = 2.33,
 > 0.05).
.2. Effects of acute and chronic administration of the
ydroalcoholic extract of Achillea millefolium L. in the open-ﬁeld
est
In the open-ﬁeld test, no difference was observed in locomo-
or activity (number of lines crossed) between groups (Table 1)
fter acute (F3,36 = 2.02, P > 0.05) and chronic treatment (F3,36 = 2.73,
 = 0.057). Additionally, no difference was found in rearing and
rooming after acute and chronic treatment (all Fs < 2.05, P > 0.10).
o effect was found in the number of fecal boluses (acute:
3,40 = 1.25, P > 0.05; chronic: H3,40 = 2.54, P > 0.05).
.3. Effects of acute and chronic administration of the
ydroalcoholic extract of Achillea millefolium L. in the
arble-burying test
In the marble-burying test (Fig. 2), effects were observed after
cute (F5,54 = 3.06, P < 0.05) and chronic treatment (F5,54 = 7.52,
 < 0.001). Acute Achillea millefolium (30, 100, and 300 mg/kg) and
iazepam administration reduced the number of marbles buried
ompared with the vehicle group (all P < 0.05). Chronic Achillea
illefolium (30 and 300 mg/kg) and diazepam administration also
educed marble-burying behavior (all P < 0.01).
.4. Effects of picrotoxin and ﬂumazenil pretreatment on the
nxiolytic-like effect of acute administration of the hydroalcoholic
xtract of Achillea millefolium L. in the elevated plus maze and
pen-ﬁeld test
Fig. 3 shows the effects of Achillea millefolium in the elevated plus
aze after pretreatment with ﬂumazenil and picrotoxin. Differ-
nces were observed between groups in the percentage of entries
nto the open arms (F5,66 = 4.68, P < 0.01) and percentage of time
pent in the open arms (F5,66 = 10.10, P < 0.001). The groups treated
ith the Achillea millefolium extract exhibited a greater percent-
ge of entries into and time spent on the open arms than the
ontrol groups (vehicle + vehicle and vehicle + ﬂumazenil or picro-
oxin; all P < 0.05), with the exception of the percentage of open
rm entries between the vehicle + ﬂumazenil and Achillea mille-
olium + ﬂumazenil groups (P > 0.10; Fig. 4). A difference was also
bserved in the percentage of open arm entries between the
chillea millefolium + vehicle and Achillea millefolium + ﬂumazenil
roups (P < 0.01). The number of total arm entries was not different
etween groups (F5,66 = 2.14, P > 0.05).
on  the open arms, percentage of entries into the open arms, and total num-
ber  of arm entries in 5 min in the elevated plus maze. Data are expressed as
mean ± SEM (n = 12 mice/group). aP < 0.05, aaP < 0.01, aaaP < 0.001, compared with
vehicle + vehicle; bP < 0.05, bbP < 0.01, compared with vehicle + ﬂumazenil and vehi-
cle + picrotoxin; ddP < 0.01, compared with Achillea millefolium + vehicle.
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Table 2
Effects of acute pretreatment with ﬂumazenil (1.0 mg/kg, i.p.) and picrotoxin (1.0 mg/kg, i.p.) on the effects of the hydroalcoholic extract of Achillea millefolium L. (300 mg/kg,
p.o.)  on open-ﬁeld behavior in male mice.
Locomotor activity (number of lines crossed) Rearing (number) Grooming time (s)
Vehicle + vehicle 48 ± 7 11 ± 3 9 ± 2
Achillea millefolium + vehicle 56 ± 4 14 ± 4 9 ± 3
Vehicle + ﬂumazenil 35 ± 5 5 ± 1* 8 ± 1
Achillea millefolium + ﬂumazenil 63 ± 8 13 ± 2 12 ± 2
Vehicle + picrotoxin 29 ± 8 2 ± 1* 6 ± 2
Achillea millefolium + picrotoxin 26 ± 7 4 ± 2* 4 ± 1*
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* P < 0.05, compared with vehicle + vehicle.
In the open-ﬁeld test (Table 2), changes were observed in
ocomotor activity (F5,66 = 3.74, P < 0.01) and rearing (F5,66 = 6.67,
 < 0.001). A difference in locomotor activity was only seen between
he Achillea millefolium + ﬂumazenil and vehicle + picrotoxin and
etween the Achillea millefolium + ﬂumazenil and Achillea mille-
olium + picrotoxin groups (P < 0.03). Rearing was  reduced by
ehicle + picrotoxin, vehicle + ﬂumazenil, and Achillea mille-
olium + picrotoxin treatments compared with vehicle + vehicle,
chillea millefolium + vehicle, and Achillea millefolium + ﬂumazenil
reatments (all P < 0.05). No difference was seen in grooming
F7,63 = 1.398, P > 0.05) and defecation (H7,63 = 0.68, P < 0.05).
.5. [3H]-ﬂunitrazepam binding
The crude extract of Achillea millefolium (1–100 g/ml) did not
lter the speciﬁc binding of [3H]-ﬂunitrazepam on membranes of
at brain in vitro (Fig. 4). Diazepam (10 M)  was used as a pos-
tive control and reduced [3H]-ﬂunitrazepam-speciﬁc binding by
6 ± 1% (Fig. 4).
.6. The effects of acute administration of Achillea millefolium,
pigenin and diazepam in the elevated plus-maze and
arble-burying test
The results of acute administration of apigenin in the elevated
lus maze are shown in Fig. 5. One-way ANOVA indicated a dif-
erence between groups in the percentage of entries into the open
rms (F5,84 = 8.352, P < 0.0001) and in the percentage of time spent
n the open arms (F5,84 = 19.11, P < 0.0001). Both diazepam and the
chillea millefolium extract (300 mg/kg) increased the percentage
f entries into open arms compared with vehicle (all P < 0.05). On
he other hand, apigenin highest dose (3.0 mg/kg) decreased the
ercentage of entries into open arms when compared to other
roups. Achillea millefolium extract (300 mg/kg) exhibited a higher
ercentage of time spent in open arms than other groups, includ-
ng diazepam (all P < 0.01). Diazepam also increased time spent in
ig. 4. Effects of the Achillea millefolium extract (1–100 g/ml) and diazepam
10 g/ml) on [3H]-ﬂunitrazepam binding in rat brain membranes. Data are
xpressed as mean ± SEM (n = 4/triplicate). aaaP < 0.001, compared with vehicle.
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Fig. 5. Effects of acute oral administration of the hydroalcoholic extract of Achillea
millefolium (AM, 300 mg/kg), diazepam (DZP, 0.75 mg/kg) or apigenin (AP, 0.1, 1.0,
and 3.0 mg/kg) on the percentage of time spent on the open arms, percentage of
entries into the open arms, and total number of arm entries in 5 min  in the elevated
plus maze. Data are expressed as mean ± SEM (n = 15 mice/group). aP < 0.05, and
aaaP < 0.001, compared with vehicle.
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lea  millefolium (AM, 300 mg/kg), diazepam (DZP, 0.75 mg/kg) or apigenin (AP, 0.1,
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p.0,  and 3.0 mg/kg) in the marble-burying test. A marble was  considered buried
hen it was  at least two-thirds buried with bedding material. Data are expressed
s  mean ± SEM (n = 15–14 mice/group). aP < 0.05 compared with vehicle.
pen arms when compared to vehicle and apigenin groups. The
umber of total arm entries also exhibited a signiﬁcant difference
F5,54 = 3.84, P < 0.01). Achillea millefolium extract (300 mg/kg) and
iazepam increased the total number of arm entries when com-
ared to vehicle group (both P < 0.02).
Similar results were seen in the marble-burying test (Fig. 6):
iazepam and the Achillea millefolium extract (300 mg/kg)
ecreased the number of marbles buried compared to all other
roups, while apigenin 1.0 mg/kg increased the number of mar-
les buried compared to vehicle (F5,81 = 13.58, P < 0.0001; all groups
omparisons P < 0.01).
. Discussion
The main ﬁndings of the present study were the anxiolytic-
ike effects of the hydroalcoholic extract of Achillea millefolium L.
n validated animal models of anxiolytic drug screening (elevated
lus maze and marble-burying test). The binding data showed that
ABA/BDZ mechanisms do not mediate these effects. These results
xtended previous ﬁndings in female rats in an operant conﬂict
rocedure with an aqueous extract of Achillea millefolium L. ﬂow-
rs (Molina-Hernandez et al., 2004). Because the present animal
odels did not require water or food deprivation or shock delivery,
he results also indicate that the anxiolytic-like effects of Achillea
illefolium L. were not attributable to changes in appetitive behav-
or or pain sensitivity (Rodgers et al., 1997; Carobrez and Bertoglio,
005), which can induce false-positive results in operant conﬂict
rocedures. This is an important issue because of the well-known
ssertion that Achillea millefolium exerts analgesic effects, which
as partially conﬁrmed by a reduction in writhing induced by
cetic acid (Pires et al., 2009). Furthermore, the effect of the extract
as not attributable to changes in locomotor activity because no
hanges was seen in the number of total arm entries in the elevated
lus maze or in the number of lines crossed in the open-ﬁeld test
Lister, 1987; de Castro et al., 2007; Raupp et al., 2008). This absence
f locomotor impairment is consistent with Pires et al. (2009),
hom also did not ﬁnd locomotor activity or motor coordination
lterations after administration of a hydroalcoholic extract of the
erial parts (with the exception of ﬂowers) of Achillea millefolium
. The doses of 30 and 300 mg/kg Achillea millefolium extract in the
resent study correspond to human doses of 2.43 and 24.3 mg/kg,armacology 140 (2012) 46– 54
respectively (Reagan-Shaw et al., 2008). Considering a person with
70 kg body weight, these doses correspond to 170 mg and 1.7 g,
respectively. These doses are close to what is recommended by
European Medicines Agency for oral use of Achillea millefolium,
which is 2 g in 250 mL  (infusion), once or twice daily (European
Medicines Agency, 2011). Thus, the effective doses for anxiolytic-
like effect found in the present study are similar to those used in
traditional preparation. Interestingly, the anxiolytic-like effect of
Achillea millefolium was seen in the elevated plus maze test after
repeated treatment (25 days), suggesting the absence of tolerance
to this effect after short-term administration, which is similar to
diazepam.
The search for new anxiolytic drugs using ethopharmacological
approaches attempts to ﬁnd drugs with new mechanism of action.
Benzodiazepine and GABAA receptor antagonists (ﬂumazenil and
picrotoxin, respectively) have been used to evaluate the involve-
ment of GABA/BDZ mechanisms in the anxiolytic-like effects of
drugs (e.g., Reddy and Kulkarni, 1996; Dombrowski et al., 2006;
Lolli et al., 2007; Duarte et al., 2008; Kamei et al., 2009). Picro-
toxin did not alter the anxiolytic-like effects of Achillea millefolium
in any of the anxiety measures in the elevated plus maze, whereas
ﬂumazenil blocked only the increase in the percentage of open arm
entries. This effect of the combination of ﬂumazenil plus Achillea
millefolium extract in the elevated plus maze in the present study
is puzzling because we would have expected that both open arm
parameters would be the same as the pattern seen in several pre-
vious studies (e.g., Lolli et al., 2007), and both loaded heavily on
the same factor in the factor analysis (e.g., Lister, 1987; Cruz et al.,
1994; Rodgers and Johnson, 1995). However, one can see in the
literature some studies that found a similar discrepancy (i.e., dif-
ferent sensitivity of percent open arm entries and percent time
spent in the open arms) in response to speciﬁc drugs at certain
doses, such as 20 mg/kg bretazenil and 10 mg/kg chlordiazepox-
ide (Cole and Rodgers, 1993), 10 mg/kg FG 7142 (Lister, 1987),
and PK 8165 (Pellow and File, 1986). In this situation, the con-
clusion of the authors was an anxiolytic-like (Cole and Rodgers,
1993) or anxiogenic-like (Pellow and File, 1986; Lister, 1987) effect
of the treatment. Furthermore, ﬂumazenil occasionally did not
reverse all of the effects of diazepam in the elevated plus maze
(e.g., Duarte et al., 2008). The ﬂumazenil plus Achillea millefolium
extract results could be considered an anxiolytic-like effect because
the percent time spent in the open arm was signiﬁcantly greater
than controls. The [3H]-ﬂunitrazepam binding assay tested the
putative action of the Achillea millefolium extract at the benzo-
diazepine binding site. The Achillea millefolium extract was not
able to displace [3H]-ﬂunitrazepam binding, whereas diazepam
reduced [3H]-ﬂunitrazepam-speciﬁc binding, suggesting that the
Achillea millefolium extract does not have a central benzodiazepine-
like action. However, although the behavioral and binding results
would appear to indicate that GABA/benzodiazepine did not medi-
ate the anxiolytic-like effect of the extract, this conclusion must be
viewed carefully. Thus, the hypothesis deserves further study.
Altogether, these results suggest that the Achillea millefolium
extract may  act via a non-BDZ/-aminobutyric acid mecha-
nism. This is an interesting ﬁnding since it differentiates Achillea
millefolium from benzodiazepines, the most widely prescribed anx-
iolytic drug class, and even from other plants with anxiolytic effect
(Houghton, 1999; Carlini, 2003; Lolli et al., 2007; Duarte et al., 2008;
Benke et al., 2009). For example, ﬂumazenil, at a dose that does not
affect behavioral indices per se,  blocked the anxiolytic-like effect
of Cymbopogon citratus (i.e., increased the time spent in the light
compartment in the light/dark test; Costa et al., 2011) and Passi-
ﬂora actinina (i.e., increased the percent open arm time and entries
in the elevated plus maze; Lolli et al., 2007).
Apigenin, in a dose range that corresponds to the con-
tent of 300 mg/kg Achillea millefolium extract (0.3 and 3.0 mg/kg
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pigenin), did not exert any anxiolytic-like effect in the ele-
ated plus maze or marble-burying test. These results did not
orroborate some data from the literature that suggested an
nxiolytic-like effect of 3.0 mg/kg apigenin in C F1 mice tested
n the elevated plus maze (Viola et al., 1995). However, Zanoli
t al. (2000) and Avallone et al. (2000) also did not observe any
ffect in the light/dark test (0.5–10 mg/kg, i.p.) and elevated plus
aze (1–25 mg/kg, i.p.) in Sprague-Dawley rats. These contradic-
ory results may  be attributable to differences between animal
odels or species/strains. Furthermore, the intermediate dose of
.0 mg/kg apigenin increased the number of marbles buried and
he higher dose of 3.0 mg/kg apigenin decreased the percentage
f entries into open arms, reﬂecting an anxiogenic-like effect.
hese results are consistent with the apigenin-induced decrease
n the latency of picrotoxin-induced convulsions (Avallone et al.,
000) and apigenin-induced decrease in GABA-activated currents
Avallone et al., 2000). Under the same experimental conditions,
pigenin did not reproduce the anxiolytic-like effect of Achillea
illefolium extract, indicating that apigenin did not contribute
o the anxiolytic-like effect of Achillea millefolium extract in the
resent study.
. Conclusion
In conclusion, the present results indicate that the hydroal-
oholic extract of the aerial parts of Achillea millefolium L. has
nxiolytic-like effects. This effect did not present tolerance after
hort-term, repeated administration and is likely not mediated by
ABAA/BDZ receptors. Thus, Achillea millefolium L. may  be a promis-
ng candidate for future development as a new anxiolytic drug.
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